https://doi.org/10.1351/goldbook.H02875
A hybrid
cell line
resulting from the fusion of a specific antibody
-producing spleen cell (lymphocyte) with a myeloma cell, which has the growth characteristics of the myeloma component and the antibody
-secreting characteristics of the lymphocyte, and will multiply to become a source of pure monoclonal antibody
.